98mTC-CIM-ANT

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name98mTC-CIM-ANT
Drug Alias Name99mTC-chelator SSTR2 antagonist (Molecular Insight)
ClassificationRadiation-emitting products
Mechanisms of ActionSomatostatin receptor 2 antagonists
TargetsSomatostatin receptor 2
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Insight Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeuroendocrine Tumors

Other Information

ATC CodeN/A
Related LinksN/A